Status:

RECRUITING

Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial

Lead Sponsor:

Dokuz Eylul University

Collaborating Sponsors:

The Scientific and Technological Research Council of Turkey

Conditions:

Obsessive Compulsive Disorder (OCD)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This randomized controlled trial examines the effects of a mobile-based gamified combined cognitive bias modification (CBM-C) intervention on obsessive-compulsive symptoms, obsessive beliefs, attentio...

Detailed Description

Cognitive Bias Modification (CBM) is a cognitive intervention that experimentally modifies cognitive biases by using a series of disorder-related stimuli designed to manipulate cognitive processes rel...

Eligibility Criteria

Inclusion

  • Age 18 years or older
  • Primary diagnosis of obsessive-compulsive disorder (OCD), confirmed by a licensed clinician using the Structured Clinical Interview for DSM-5 (SCID-5)
  • No current suicidal ideation or psychotic symptoms
  • Access to the internet and a mobile phone
  • Stable psychiatric medication use for at least one month prior to enrollment, with no changes in dosage during the 4-week intervention period
  • No current neurological or medical condition that would interfere with participation
  • Ability to perceive colored visual stimuli (e.g., no color blindness)
  • Not currently enrolled in another intervention-based study
  • Not receiving any other form of psychological treatment at the time of participation

Exclusion

  • Presence of active suicidal ideation or psychotic symptoms
  • Unstable psychiatric medication use (e.g., recent dose change within the past month or expected change during the intervention period)
  • Significant neurological or medical illness that may interfere with participation
  • Visual impairments that would prevent accurate perception of colored stimuli (e.g., color blindness)
  • Current participation in another clinical trial involving psychological intervention
  • Receiving concurrent psychotherapy or other psychological treatments outside of the study

Key Trial Info

Start Date :

May 14 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 2 2027

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06941155

Start Date

May 14 2025

End Date

April 2 2027

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dokuz Eylul University Hospital

Izmir, Turkey (Türkiye), 35340